BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22320106)

  • 1. [Idiopathic pulmonary fibrosis -- progress in sight].
    Kaarteenaho R; Hodgson U; Myllärniemi M
    Duodecim; 2011; 127(24):2639-45. PubMed ID: 22320106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pirfenidone treatment of idiopathic pulmonary fibrosis.
    Azuma A
    Ther Adv Respir Dis; 2012 Apr; 6(2):107-14. PubMed ID: 22333982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirfenidone: significant treatment effects in idiopathic pulmonary fibrosis.
    Hilberg O; Simonsen U; du Bois R; Bendstrup E
    Clin Respir J; 2012 Jul; 6(3):131-43. PubMed ID: 22697264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolving pharmacotherapy of pulmonary fibrosis.
    Lota HK; Wells AU
    Expert Opin Pharmacother; 2013 Jan; 14(1):79-89. PubMed ID: 23265249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The questionable efficacy of pirfenidone in IPF.
    Mathai SC; Polito AJ
    Am J Respir Crit Care Med; 2005 Nov; 172(9):1228. PubMed ID: 16249323
    [No Abstract]   [Full Text] [Related]  

  • 6. Pirfenidone: a novel agent for the treatment of idiopathic pulmonary fibrosis.
    Potts J; Yogaratnam D
    Ann Pharmacother; 2013 Mar; 47(3):361-7. PubMed ID: 23404802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal treatment for idiopathic pulmonary fibrosis.
    Maher TM; Wells AU
    Thorax; 2008 Dec; 63(12):1120-1; author reply 1121. PubMed ID: 19020278
    [No Abstract]   [Full Text] [Related]  

  • 8. New developments in the therapy of pulmonary fibrosis.
    Scriabine A; Rabin DU
    Adv Pharmacol; 2009; 57():419-64. PubMed ID: 20230768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor choice of primary outcome in a clinical trial of pirfenidone in patients with IPF.
    Levitt J; Gould MK
    Am J Respir Crit Care Med; 2005 Nov; 172(9):1228-9; author reply 1229. PubMed ID: 16249322
    [No Abstract]   [Full Text] [Related]  

  • 10. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
    Azuma A; Nukiwa T; Tsuboi E; Suga M; Abe S; Nakata K; Taguchi Y; Nagai S; Itoh H; Ohi M; Sato A; Kudoh S
    Am J Respir Crit Care Med; 2005 May; 171(9):1040-7. PubMed ID: 15665326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirfenidone for the treatment of idiopathic pulmonary fibrosis.
    Poletti V; Ravaglia C; Tomassetti S
    Expert Rev Respir Med; 2014 Oct; 8(5):539-45. PubMed ID: 25113033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pirfenidone. First, do no harm.
    Prescrire Int; 2013 May; 22(138):117-9. PubMed ID: 23819168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis].
    Bonella F; Wessendorf TE; Costabel U
    Dtsch Med Wochenschr; 2013 Mar; 138(11):518-23. PubMed ID: 23423955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics and management of idiopathic pulmonary fibrosis: INSIGHTS-IPF registry].
    Behr J; Hoeper MM; Kreuter M; Klotsche J; Wirtz H; Pittrow D
    Dtsch Med Wochenschr; 2012 Dec; 137(49):2586-8. PubMed ID: 23188642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pirfenidone for the treatment of idiopathic pulmonary fibrosis.
    Xaubet A; Serrano-Mollar A; Ancochea J
    Expert Opin Pharmacother; 2014 Feb; 15(2):275-81. PubMed ID: 24308635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expectation of new treatments for idiopathic interstitial pneumonias].
    Azuma A
    Nihon Ronen Igakkai Zasshi; 2005 Jan; 42(1):27-30. PubMed ID: 15732351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic pulmonary fibrosis and pirfenidone.
    Collard HR
    Eur Respir J; 2010 Apr; 35(4):728-9. PubMed ID: 20356985
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice.
    Okuda R; Hagiwara E; Baba T; Kitamura H; Kato T; Ogura T
    Respir Med; 2013 Sep; 107(9):1431-7. PubMed ID: 23849626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A safety evaluation of pirfenidone for the treatment of idiopathic pulmonary fibrosis.
    Anderson A; Shifren A; Nathan SD
    Expert Opin Drug Saf; 2016 Jul; 15(7):975-82. PubMed ID: 27177012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pirfenidone: a novel potential therapeutic agent in the management of chronic allograft rejection.
    Dosanjh A
    Transplant Proc; 2007 Sep; 39(7):2153-6. PubMed ID: 17889122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.